(SPAC) Special Purpose Acquisition Investigation: IONQ, LVOX, MTTR, …

(SPAC) Special Purpose Acquisition Investigation: IONQ, LVOX, MTTR, …

Facebook
Twitter
LinkedIn

SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) — Shareholder law firm Johnson Fistel, LLP is investigating possible violations of law related to the following special purpose entities (“SPACs”): IonQ, Inc. w/k/a dMY Technology Group, Inc. IONQ, LiveVox Holdings, Inc. f/k/a Crescent Acquisition Corporation LVOX, Matterport, Inc. w/k/a Gores Holdings VI, Inc. MTTRand Mirion Technologies, Inc. w/k/a GS Acquisition Holdings Corp II Me.

If you are an investor who has suffered losses related to any of the SPACs purchased below: Click or paste the following web address into your browser to submit your losses:

IonQ, Inc. w/k/a dMY Technology Group, Inc. IONQ https://www.johnsonfistel.com/investigations/ionq-inc-dmy-technology-group-inc

LiveVox Holdings, Inc. f/k/a Crescent Acquisition Corporation LVOX: https://www.johnsonfistel.com/investigations/livevox-holdings-inc-crescent-acquisition

Matterport, Inc. w/k/a Gores Holdings VI, Inc. MTTR https://www.johnsonfistel.com/investigations/matterport-inc-gores-holdings-vi-inc

Mirion Technologies, Inc. w/k/a GS Acquisition Holdings Corp II Me: https://www.johnsonfistel.com/investigations/mirion-technologies-inc-gs-acquisition-holdings

Or contact Jim Baker at for more information jimb@johnsonfistula.com or (619) 814-4471

About Johnson Fistula, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in class action lawsuits involving shareholder derivatives and securities. Johnson Fistula seeks to recover losses incurred as a result of violations of federal securities laws. For more information about the firm and its attorneys, visit http://www.johnsonfistula.com. attorney advertising. Past results do not guarantee future results.

Contact:
Johnson Fistula, LLP
jim baker, 619-814-4471
Investor Relations
jimb@johnsonfistula.com


[ad_2]

Source story

More to explorer